Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1–13) or MK-801 in a nerve-ligation model of peripheral neuropathy

[1]  G. Wilcox,et al.  Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone , 1996, Pain.

[2]  F. Porreca,et al.  Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. , 1995, The Journal of pharmacology and experimental therapeutics.

[3]  F. Porreca,et al.  Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury , 1995, Neuroscience Letters.

[4]  F. Porreca,et al.  The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive , 1995, Neuroscience Letters.

[5]  S. Harrison,et al.  Peri-administration of clonidine or MK801 delays but does not prevent the development of mechanical hyperalgesia in a model of mononeuropathy in the rat , 1995, Neuroscience Letters.

[6]  C. Woolf,et al.  Noxious stimuli induce an N-methyl-d-aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implications for the treatment of mechanical allodynia , 1995, Pain.

[7]  L. Chen,et al.  The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  T. Yaksh,et al.  Analysis of Drug Interaction between Intrathecal Clonidine and MK‐801 in Peripheral Neuropathic Pain Rat Model , 1995, Anesthesiology.

[9]  S. Yom,et al.  Norepinephrine Rekindles Mechanical Allodynia in Sympathectomized Neuropathic Rat , 1995 .

[10]  T. Yaksh,et al.  Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  V. Shukla,et al.  Non-opioid effects of dynorphins: possible role of the NMDA receptor. , 1994, Trends in pharmacological sciences.

[12]  A. Yakovlev,et al.  Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. , 1994, Molecular and chemical neuropathology.

[13]  T. Doubell,et al.  The pathophysiology of chronic pain — increased sensitivity to low threshold Aβ-fibre inputs , 1994, Current Opinion in Neurobiology.

[14]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[15]  G. Bennett,et al.  Neuropathic pain sensations are differentially sensitive to dextrorphan , 1994, Neuroreport.

[16]  Xiao-jun Xu,et al.  Cholecystokinin and morphine analgesia: variations on a theme. , 1994, Trends in pharmacological sciences.

[17]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[18]  R. Coggeshall,et al.  Peripheral nerve injury triggers central sprouting of myelinated afferents , 1992, Nature.

[19]  R. Dubner,et al.  Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation , 1991, Brain Research.

[20]  Z. Seltzer,et al.  Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge , 1991, Pain.

[21]  Clifford J. Woolf,et al.  The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states , 1991, Pain.

[22]  M. Iadarola,et al.  Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy , 1990, Peptides.

[23]  A. Faden.  Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury , 1990, Annals of neurology.

[24]  D. Massardier,et al.  A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor. , 1989, European journal of pharmacology.

[25]  J. Holaday,et al.  Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function. , 1988, The Journal of pharmacology and experimental therapeutics.

[26]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[27]  B. Meyerson,et al.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.

[28]  R. Caudle,et al.  A novel interaction between dynorphin(1–13) and an N-methyl-d-aspartate site , 1988, Brain Research.

[29]  D. Lodge,et al.  Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat , 1987, Brain Research.

[30]  G. Wilcox,et al.  Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. , 1987, The Journal of pharmacology and experimental therapeutics.

[31]  G. Wilcox,et al.  Phencyclidine selectively blocks a spinal action of N-methyl-d-aspartate in mice , 1986, Neuroscience Letters.

[32]  R. Payne.  Neuropathic Pain Syndromes, with Special Reference to Causalgia and Reflex Sympathetic Dystrophy , 1986 .

[33]  A. Faden,et al.  Effects of traumatic injury on dynorphin immunoreactivity in spinal cord , 1985, Neuropeptides.

[34]  H. Akil,et al.  Nonopiate effects of dynorphin and des-Tyr-dynorphin. , 1982, Science.

[35]  R. Twycross,et al.  Morphine and Diamorphine in the Terminally Ill Patient , 1982, Acta anaesthesiologica Scandinavica. Supplementum.

[36]  T. Yaksh,et al.  Chronic catheterization of the spinal subarachnoid space , 1976, Physiology & Behavior.